Brandinium

Trademark search for:

DERMOWAS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-04-25 — Application filed
  • 2016-06-30 — Sn assigned for sect 66a appl from ib
  • 2016-07-01 — Application filed
  • 2016-07-05 — Application filed
  • 2016-08-10 — Assigned to examiner
  • 2016-08-11 — Final disposition recorded
  • 2016-08-12 — Office action issued
  • 2016-08-12 — Office action issued
  • 2016-08-12 — Office action issued
  • 2016-09-02 — Office action issued
  • 2017-02-10 — Office action issued
  • 2017-02-25 — Assigned to lie
  • 2017-03-01 — Correspondence received in law office
  • 2017-03-01 — Teas/email correspondence entered
  • 2017-04-12 — Assigned to examiner
  • 2017-05-03 — Examiners amendment -written
  • 2017-05-03 — Examiners amendment e-mailed
  • 2017-05-03 — Notification of examiners amendment e-mailed
  • 2017-05-03 — Examiner's amendment entered
  • 2017-05-03 — Approved for pub - principal register
  • 2017-05-09 — Law office publication review completed
  • 2017-05-24 — Notification of notice of publication e-mailed
  • 2017-06-07 — Notice of start of opposition period created, to be sent to ib
  • 2017-06-07 — Notification of possible opposition sent to ib
  • 2017-06-13 — Published for opposition
  • 2017-06-13 — Official gazette publication confirmation e-mailed
  • 2017-06-24 — Notification processed by ib
  • 2017-08-29 — Registered-principal register
  • 2017-10-31 — Teas revoke/app/change addr of atty/dom rep received
  • 2017-10-31 — Attorney/dom.rep.revoked and/or appointed
  • 2017-11-17 — New representative at ib received
  • 2017-11-29 — Final disposition recorded
  • 2017-12-12 — Generic madrid transaction created
  • 2017-12-13 — Generic madrid transaction sent to ib
  • 2018-01-19 — Final disposition recorded
  • 2022-08-29 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2022-09-24 — New representative at ib received
  • 2023-01-24 — Teas change of owner address received
  • 2023-01-24 — Teas revoke/app/change addr of atty/dom rep received
  • 2023-01-24 — Attorney/dom.rep.revoked and/or appointed
  • 2023-01-24 — Teas change of domestic representatives address
  • 2023-01-24 — Teas change of correspondence received
  • 2023-01-24 — Applicant/correspondence changes (non-responsive) entered
  • 2024-03-15 — Cancelled section 71
  • 2024-03-15 — Final status recorded
  • 2024-11-16 — Total invalidation of reg ext protection created
  • 2024-11-29 — Invalidation processed
  • 2024-11-30 — Total invalidation of reg ext protection sent to ib
  • 2024-12-21 — Total invalidation processed by the ib
  • 2025-12-11 — New representative at ib received

Owner Information

Dr. August Wolff GmbH & Co. KG Arzneimittel
DE
Dr. August Wolff GmbH & Co. KG Arzneimittel
DE
Dr. August Wolff GmbH & Co. KG Arzneimittel
DE

Correspondent

Karl M. Zielaznicki Troutman Pepper Hamilton Sanders LLP
600 Peachtree Street, NE, Suite 3000
c/o TM DKT CLK
Atlanta, GA 30308

Filing Details

Filing Date:
2016-04-25
Status Date:
2024-03-15
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.